Rhythm Pharmaceuticals Inc. (RYTM) Company Profile & Statistics

Rhythm Pharmaceuticals Inc.
RYTM
(Nasdaq - US)
Open
57.31
+1.08 (+1.92%)
in:usd•As of: Nov 18, 2024 12:49 UTC -5
Open
57.12
High
57.84
Low
55.99

About Rhythm Pharmaceuticals Inc.

CEO

David P. Meeker

Headquarters

222 berkeley street, 12th floor

boston, ma 02116, united states

Auditor

Ernst & Young LLP

Employees

226

Share Holders

Website

www.rhythmtx.com

Industry

biotechnology

Sector

health technology

Company Overview

Rhythm Pharmaceuticals, Inc. is a biopharmaceutical company. It focused on the development and commercialization of peptide therapeutics for the treatment of rare genetic deficiencies which result in life-threatening metabolic disorders. The Company's product candidate principally consists of setmelanotide, a potent, first-in-class melanocortin-4 receptor or MC4R, agonist for the treatment of rare genetic disorders of obesity. Rhythm Pharmaceuticals, Inc. is based in Boston, MA.

Rhythm Pharmaceuticals Inc. Statistics

Valuation Measures

Market Capitalization ²	3.52B
Enterprise Value	3.47B
Enterprise Value/EBITDA (ttm)	-13.87
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	306.51
Price to Sales (ttm)	30.71
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	88.55%
Operating Margin (ttm)	-230.07%
Profit Margin (ttm)	-241.72%
Return on Equity (ttm)	-367.36%
Return on Invested Capital (ttm)	-300.65%
Return on Assets (ttm)	-77.47%

Income Statement

Revenue (ttm)	112.53M
Revenue Per Share (ttm)	1.83
Gross Profit (ttm)	99.72M
EBITDA (ttm)³	-250.56M
Net Income Avi to Common (ttm)	-261.54M
Diluted EPS (ttm)	-4.33

Share Statistics

Beta (5Y Monthly)	2.09
52-Week Change	71.90%
S&P500 52-Week Change	29.69%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	61.46M
Dividend Yield	0.00%
Float ⁴	58.02M
% Held by Insiders	5.60%
% Held by Institutions	N/A

Balance Sheet

Total Cash (mrq)	298.39M
Total Cash Per Share (mrq)	4.86
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	3.49%
Quick Ratio (mrq)	3.34%
Book Value Per Share (mrq)	2.49

Cash Flow

Operating Cash Flow Per Share (ytd)	-1.55
Free Cash Flow (ytd)	-135.53M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Rhythm Pharmaceuticals Inc.

Trade With A Regulated Broker